ChemoCentryx Securities Litigation

Homyk v. ChemoCentryx, Inc. et al. United States District Court for the Northern District of California Case No. 4:21-cv-03343-JST

Welcome to the ChemoCentryx Securities Litigation Website

 

The information contained on this website is only a summary of the information presented in more detail in the Notice of (I) Proposed Class Action Settlement; (II) Settlement Hearing; and (III) Motion for Attorneys’ Fees and Litigation Expenses (the “Settlement Notice”) Because this website is just a summary, you should review the Notice Settlement for additional details.


 

The Court’s hearing on the fairness of the Settlement and related matters which was scheduled for October 22, 2026, has been rescheduled for October 29, 2026, at 2:00 p.m. Pacific time. The hearing will be held by Zoom videoconference.

 

Any Class Member or member of the public who wishes to listen to or participate in the hearing may do so by contacting Lead Counsel at [email protected] or may visit https://www.cand.uscourts.gov/jst to obtain the access information.

 

 

Summary of the Action and Settlement

 

This website relates to a proposed Settlement of claims in a pending securities class action brought by investors alleging that ChemoCentryx and its former President and Chief Executive Officer, Dr. Thomas J. Schall (together, “Defendants”), violated the federal securities laws by making material misrepresentations during the Class Period regarding ChemoCentryx’s ADVOCATE study, the Company’s Phase 3 clinical trial of its vasculitis drug avacopan, and concerning the Company’s communications with the FDA related to the approval of avacopan.  Defendants deny all allegations in the Action and deny any violations of the federal securities law. If the Court approves the proposed Settlement, the Action will be dismissed and members of the Class will settle and release all Released Plaintiff’s Claims, as defined in paragraph 37 of the Settlement Notice.

 

Subject to Court approval, Class Representative, Indiana Public Retirement System on behalf of itself and the Class, has agreed to settle the Action in exchange for a settlement payment of $69,000,000 in cash (the “Settlement Amount”). 

 

If you are a member of the Class, your rights will be affected and you may be eligible for a payment from the Settlement. The Class consists of:

 

All persons who purchased or otherwise acquired the common stock of ChemoCentryx, Inc. (“ChemoCentryx” or the “Company”) from November 26, 2019 through May 6, 2021, inclusive (the “Class Period”), and were damaged thereby.

 

Certain persons and entities are excluded from the Class by definition (see paragraph 28 of the Settlement Notice). Also excluded from the Class are persons and entities who excluded themselves from the Class pursuant to the Class Notice. A list of the persons and entities who excluded themselves is available here. However, those persons or entities may choose to participate in the Settlement by following the instructions in paragraphs 59-60 of the Settlement Notice

 

Please read the Settlement Notice to fully understand your rights. Copies of the Settlement Notice and Claim Form can be found in the menu at the top of this page.

 

 

The deadline to submit a Claim Form to be eligible to participate in the proposed Settlement is October 1, 2026.  Payments to eligible claimants will be made only if the Court approves the Settlement and a plan of allocation, and any appeals are resolved, and only after the completion of all claims processing. Please be patient, as this process will take some time to complete.

 

YOUR LEGAL RIGHTS AND OPTIONS IN THE SETTLEMENT:
SUBMIT A CLAIM FORM POSTMARKED OR SUBMITTED ONLINE NO LATER THAN OCTOBER 1, 2026.

This is the only way to be eligible to receive a payment from the Settlement Fund. If you are a Class Member, you will be bound by the Settlement as approved by the Court and you will give up any Released Plaintiff's Claims (defined in paragraph 37 of the Settlement Notice) that you have against Defendants and the other Defendants' Releasees (defined in paragraph 38 of the Settlement Notice), so it is in your interest to submit a Claim Form. 

OBJECT TO THE SETTLEMENT BY SUBMITTING A WRITTEN OBJECTION SO THAT IT IS POSTMARKED OR FILED NO LATER THAN SEPTEMBER 21, 2026. If you do not like the proposed Settlement, the proposed Plan of Allocation, or the request for attorneys’ fees and Litigation Expenses, you may write to the Court and explain why you do not like them.  You cannot object to the Settlement, the Plan of Allocation, or the fee and expense request unless you are a Class Member. This is the only way to be eligible to receive a payment from the Settlement Fund. 
GO TO A HEARING ON OCTOBER 29, 2026 AT 2:00 P.M. PACIFIC TIME, AND FILE A NOTICE OF INTENTION TO APPEAR SO THAT IT IS RECEIVED NO LATER THAN SEPTEMBER 21, 2026.Filing a written objection and notice of intention to appear by September 21, 2026 allows you to speak in Court, at the discretion of the Court, about the fairness of the proposed Settlement, the Plan of Allocation, and/or the request for attorneys’ fees and Litigation Expenses.  If you submit a written objection, you may (but you do not have to) attend the hearing and, at the discretion of the Court, speak to the Court about your objection.  If you do not submit a written objection, you are unlikely to be allowed to speak in Court about the fairness of the settlement.
DO NOTHING.If you are a member of the Class and you do not submit a valid Claim Form, you will not be eligible to receive any payment from the Settlement Fund.  You will, however, remain a member of the Class, which means that you give up your right to sue about the claims that are resolved by the Settlement and you will be bound by any judgments or orders entered by the Court in the Action.

 

These rights and options—and the deadlines to exercise them—are further explained in the Settlement Notice.  Please Note: the date and time of the Settlement Hearing—currently scheduled for October 29, 2026 at 2:00 p.m. Pacific Time by Zoom videoconference—is subject to change without further notice to the Class. Information on how to attend the Zoom videoconference is available at https://cand.uscourts.gov/judges/tigar-jon-s-jst/. If you plan to attend the hearing, you should check this website, or with Class Counsel as set forth above, to obtain information about how to access the Settlement Hearing and to confirm that no change to the date or time of the hearing has been made.

 

 

This website is authorized by the Court, supervised by counsel to the parties, and controlled by the Settlement Administrator approved by the Court. This is the only authorized website for this case.

For more information, please use the Contact Us page, or call (833) 522-2606. You may also write to:


ChemoCentryx Securities Litigation
c/o Kroll Settlement Administration
P.O. Box 5013
New York, NY 10150-5013

Important Dates

  • Claim Form Deadline

    October 1, 2026
    You must submit a valid Claim Form to be potentially eligible for a payment from this Settlement. Claim Forms must be submitted online by October 1, 2026, or, if mailed, postmarked no later than October 1, 2026.
  • Objection Deadline

    September 21, 2026
    If you do not like the proposed Settlement, the proposed Plan of Allocation, or the request for attorneys’ fees and Litigation Expenses, you may write to the Court and explain why you do not like them. You cannot object to the Settlement, the Plan of Allocation, or the fee and expense request unless you are a Class Member. Objections must be postmarked or filed no later than September 21, 2026.
  • Settlement Hearing

    October 29, 2026
    The Settlement Hearing will be held on October 29, 2026, at 2:00 p.m., before the Honorable Jon S. Tigar of the United States District Court for the Northern District of California, either in person at the United States District Court for the Northern District of California, Courtroom 6 of the Ronald V. Dellums Federal Building & United States Courthouse, 1301 Clay Street, Oakland, CA 94612, or by telephone or videoconference (in the discretion of the Court).

This website is authorized by the Court, supervised by counsel to the parties, and controlled by the Settlement Administrator approved by the Court. This is the only authorized website for this case.

For more information, please use the Contact Us page, or call (833) 522-2606. You may also write to:


ChemoCentryx Securities Litigation
c/o Kroll Settlement Administration
P.O. Box 5013
New York, NY 10150-5013

Important Dates

  • Claim Form Deadline

    October 1, 2026
    You must submit a valid Claim Form to be potentially eligible for a payment from this Settlement. Claim Forms must be submitted online by October 1, 2026, or, if mailed, postmarked no later than October 1, 2026.
  • Objection Deadline

    September 21, 2026
    If you do not like the proposed Settlement, the proposed Plan of Allocation, or the request for attorneys’ fees and Litigation Expenses, you may write to the Court and explain why you do not like them. You cannot object to the Settlement, the Plan of Allocation, or the fee and expense request unless you are a Class Member. Objections must be postmarked or filed no later than September 21, 2026.
  • Settlement Hearing

    October 29, 2026
    The Settlement Hearing will be held on October 29, 2026, at 2:00 p.m., before the Honorable Jon S. Tigar of the United States District Court for the Northern District of California, either in person at the United States District Court for the Northern District of California, Courtroom 6 of the Ronald V. Dellums Federal Building & United States Courthouse, 1301 Clay Street, Oakland, CA 94612, or by telephone or videoconference (in the discretion of the Court).